Profile data is unavailable for this security.
About the company
Principal Technologies Inc. is a Canada-based company. The Company is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. It operates in one operational segment, being its operations in healthcare technology, including the project management of international scale clinical studies primarily related to medical device technologies. The Company's subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.
- Revenue in CAD (TTM)618.64k
- Net income in CAD-1.90m
- Incorporated2018
- Employees--
- LocationPrincipal Technologies Inc2500 - 700 West Georgia StreetVancouver V7Y 1B3CanadaCAN
- Phone+1 (604) 609-6112
- Fax+1 (604) 609-6145
- Websitehttps://www.principal-technologies.com/
Mergers & acquisitions
Acquired company | PTEC:CVE since announced | Transaction value |
---|---|---|
VIVOSTAT A/S | 10.00% | 8.43m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Appili Therapeutics Inc | 827.41k | -3.82m | 3.05m | 7.00 | -- | -- | -- | 3.68 | -0.0315 | -0.0315 | 0.0068 | -0.1021 | 0.3758 | -- | 0.6463 | 118,201.40 | -173.36 | -128.44 | -- | -251.87 | -- | -- | -461.35 | -2,103.81 | -- | -3.30 | -- | -- | 147.59 | -- | 59.09 | -- | 17.59 | -- |
StageZero Life Sciences Ltd | -100.00bn | -100.00bn | 4.94m | 40.00 | -- | -- | -- | -- | -- | -- | -- | -0.1192 | -- | -- | -- | -- | -- | -135.76 | -- | -- | -- | -2.74 | -- | -246.92 | 0.0204 | -- | -- | -- | -25.12 | 55.93 | -52.53 | -- | -- | -- |
Quest PharmaTech Inc | 0.00 | 13.58m | 5.10m | 0.00 | 0.3737 | 0.2205 | 0.3754 | -- | 0.0803 | 0.0803 | 0.00 | 0.136 | 0.00 | -- | -- | -- | 53.30 | 7.62 | 55.60 | 8.45 | -- | -- | -- | -- | -- | -- | 0.0417 | 0.00 | -- | -- | 95.35 | -- | -- | -- |
Hemostemix Inc | 0.00 | -1.94m | 5.25m | -- | -- | -- | -- | -- | -0.0214 | -0.0214 | 0.00 | -0.0959 | 0.00 | -- | -- | -- | -705.31 | -599.98 | -- | -- | -- | -- | -- | -- | -- | -1.74 | -- | -- | -- | -- | 52.21 | -- | -- | -- |
Innovotech Inc | 1.23m | -364.50k | 5.30m | 16.00 | -- | 7.22 | -- | 4.31 | -0.0094 | -0.0094 | 0.0315 | 0.0187 | 1.10 | 5.81 | 5.84 | -- | -32.59 | 2.90 | -37.99 | 3.56 | 68.63 | 71.56 | -29.67 | 2.19 | 2.17 | -- | 0.1115 | -- | 5.05 | 7.42 | -15.43 | -- | 35.69 | -- |
Principal Technologies Inc | 618.64k | -1.90m | 5.93m | -- | -- | 9.72 | -- | 9.58 | -0.0766 | -0.0766 | 0.0246 | 0.0165 | 0.5664 | -- | 2.92 | -- | -170.72 | -- | -445.11 | -- | 21.57 | -- | -301.45 | -- | -- | -31.95 | 0.0959 | -- | 25.43 | -- | 23.53 | -- | -- | -- |
Marvel Biosciences Corp | 0.00 | -2.10m | 6.75m | -- | -- | -- | -- | -- | -0.0529 | -0.0529 | 0.00 | -0.0693 | 0.00 | -- | -- | -- | -268.48 | -- | -- | -- | -- | -- | -- | -- | -- | -14.33 | -- | -- | -- | -- | 10.29 | -- | -- | -- |
XORTX Therapeutics Inc | 0.00 | -2.03m | 6.80m | 3.00 | -- | 1.82 | -- | -- | -0.6868 | -0.6868 | 0.00 | 1.28 | 0.00 | -- | -- | -- | -23.54 | -35.42 | -29.36 | -40.37 | -- | -- | -- | -- | -- | -- | 0.03 | -- | -- | -- | 72.04 | -- | 7.91 | -- |
Rakovina Therapeutics Inc | 0.00 | -2.94m | 8.16m | -- | -- | 1.99 | -- | -- | -0.0419 | -0.0419 | 0.00 | 0.0452 | 0.00 | -- | -- | -- | -46.65 | -- | -51.51 | -- | -- | -- | -- | -- | -- | -13.01 | 0.2652 | -- | -- | -- | 6.39 | -- | -- | -- |